Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Progyny, Inc. (PGNY : NSDQ)
 
 • Company Description   
Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States.

Number of Employees: 856

 
 • Price / Volume Information   
Yesterday's Closing Price: $24.88 Daily Weekly Monthly
20 Day Moving Average: 1,785,562 shares
Shares Outstanding: 78.33 (millions)
Market Capitalization: $1,948.90 (millions)
Beta: 0.91
52 Week High: $28.75
52 Week Low: $16.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 40.80% 33.93%
12 Week 11.82% 3.37%
Year To Date -3.12% -11.61%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1359 BROADWAY
-
NEW YORK,NY 10018
USA
ph: 212-888-3124
fax: -
investors@progyny.com http://www.progyny.com
 
 • General Corporate Information   
Officers
Peter Anevski - Chief Executive Officer and Director
David Schlanger - Chairman
Mark Livingston - Chief Financial Officer
Elizabeth Bierbower - Director
Lloyd Dean - Director

Peer Information
Progyny, Inc. (CHCR)
Progyny, Inc. (ESRX)
Progyny, Inc. (MYDP)
Progyny, Inc. (COR)
Progyny, Inc. (GBCS)
Progyny, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 74340E103
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 78.33
Most Recent Split Date: (:1)
Beta: 0.91
Market Capitalization: $1,948.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.29 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.12 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 16.80% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.21
Trailing 12 Months: 32.31
PEG Ratio: 1.32
Price Ratios
Price/Book: 4.44
Price/Cash Flow: 33.80
Price / Sales: 1.51
EPS Growth
vs. Year Ago Period: 70.59%
vs. Previous Quarter: 107.14%
Sales Growth
vs. Year Ago Period: 1.38%
vs. Previous Quarter: 3.17%
ROE
03/31/26 - 13.34
12/31/25 - 11.37
09/30/25 - 10.71
ROA
03/31/26 - 9.03
12/31/25 - 7.73
09/30/25 - 7.27
Current Ratio
03/31/26 - 2.13
12/31/25 - 2.73
09/30/25 - 2.95
Quick Ratio
03/31/26 - 2.13
12/31/25 - 2.73
09/30/25 - 2.96
Operating Margin
03/31/26 - 5.23
12/31/25 - 4.54
09/30/25 - 4.14
Net Margin
03/31/26 - 5.23
12/31/25 - 4.54
09/30/25 - 4.46
Pre-Tax Margin
03/31/26 - 8.18
12/31/25 - 7.41
09/30/25 - 7.51
Book Value
03/31/26 - 5.61
12/31/25 - 5.99
09/30/25 - 6.51
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 0.00
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©